Isabella Sperduti is an expert in Oncology at Istituto Nazionale Tumori Regina Elena (Italy). As of October 2026, ScienceLeadR ranks Isabella Sperduti in the top 1% of experts worldwide for Breast Neoplasms and Breast Diseases. Isabella Sperduti has authored 620 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,578 (community average: 125). How the SLR is computed.

LeadR Profile

1 578 ScienceLeadR Reputation 1578
Network Map

Oncology

Subspecialties: Surgery - Immunology - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Istituto Nazionale Tumori Regina Elena

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 620

Citations

Citations: 13 722 1st author: 2 Last author: 4 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Pregnancy after breast cancer: obstetrics and feto-maternal outcomes.
PMID 42677692 — pregnancy, mothers, breast neoplasms, neoplasms, obstetrics, drug therapy, breast, chemotherapy
Eur Rev Med Pharmacol Sci20260
The Role of Histology in Predicting Spread Through Air Spaces (STAS) in Non-Small Cell Lung Cancer.
PMID 42645895 — cells, lung, neoplasms, adenocarcinoma, carcinoma, non-small-cell lung, air, lung neoplasms, small cell lung carcinoma, histology
J Pers Med20260
En-Bloc Spondylectomy for spinal metastases: outcomes, indications, and cost analysis in a 40-patient retrospective study.
PMID 42414662 — retrospective studies, neoplasms, neoplasm metastasis, therapeutics, spine
Eur Spine J20260
Prospective clinical implementation of the robust optimization planning technique in long-course photon radiotherapy treatment for lung cancer.
PMID 42373409 — radiotherapy, cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, small cell lung carcinoma, therapeutics, tissues, planning techniques
Med Dosim20260
The WPG score for predicting clinically relevant postoperative pancreatic fistula after Wirsung-pancreatogastrostomy.
PMID 42334809 — fistula, pancreatic fistula, general surgery
Updates Surg20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 3 1

By status:

Completed 5

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map